OCULAR CHANGES IN METASTATIC MELANOMA PATIENTS TREATED WITH MEK INHIBITOR COBIMETINIB AND BRAF INHIBITOR VEMURAFENIB. Radiol Oncol [Internet]. 2018 May 23 [cited 2026 Oct. 26];52(2). Available from: https://www.radioloncol.com/index.php/ro/article/view/2930